Sign in

You're signed outSign in or to get full access.

KR

KKR Real Estate Finance Trust Inc. (KREF)·Q4 2024 Earnings Summary

Executive Summary

  • Q4 2024 GAAP net income was $14.6 million ($0.21 diluted EPS); Distributable Earnings were a loss of ($14.7) million ($-0.21 per share) driven by a $35.9 million realized write-off on a subordinated loan .
  • Portfolio deleveraging continued: repayments reached $457 million in Q4 and $1.5 billion for 2024; leverage fell to 3.6x total and 1.6x debt-to-equity; liquidity stood at $685 million with 79% non-mark-to-market financing .
  • Credit quality stabilized: weighted average risk rating improved to 3.1; 100% interest collected in Q4; CECL allowance decreased to $120 million ($1.74/share), reflecting resolution actions (San Carlos modification and write-off) .
  • Management expects originations to outpace repayments near term and closed ~$224 million of loans in January 2025, positioning for offensive deployment at reset values; share repurchases of ~$10 million were executed in Q4 .

What Went Well and What Went Wrong

What Went Well

  • “Repayments of $1.5 billion last year surpassed expectations driving portfolio deleveraging and high levels of liquidity, positioning KREF for new investment activity.” — President/COO Patrick Mattson .
  • “We have strong levels of liquidity with $685 million available… 79% of our financing is non-mark-to-market.” — CEO Matt Salem .
  • “In fourth quarter, we modified the San Carlos Life Science loan… the $36 million subordinated note was written off… restructured senior loan upgraded to risk rating 3.” — President/COO Patrick Mattson .

What Went Wrong

  • Distributable Earnings negative in Q4 due to a $35.9 million realized write-off; DE per share fell to ($0.21) versus $0.37 in Q3 .
  • Provision for credit losses remained a headwind ($4.6 million in Q4; $80.6 million for 2024) reflecting continued portfolio stress pockets .
  • Watch list persisted (e.g., Minneapolis office remained risk-rated 5), with management acknowledging further credit migration is possible despite improvement .

Financial Results

Quarter-over-Quarter comparison (Q2 → Q3 → Q4 2024)

MetricQ2 2024Q3 2024Q4 2024
Net Interest Income ($USD Millions)$40.4 $37.0 $35.1
Other Income ($USD Millions)$7.2 $10.0 $4.7
Provision for Credit Losses ($USD Millions)$4.5 $38.2 $4.6
Operating Expenses ($USD Millions)$17.5 $16.1 $15.6
Net Income Attributable to Common ($USD Millions)$20.2 ($13.0) $14.6
Diluted EPS ($USD)$0.29 ($0.19) $0.21
Distributable Earnings (Loss) per share ($USD)($1.57) $0.37 ($0.21)
Dividend per share ($USD)$0.25 $0.25 $0.25

Year-over-Year comparison (Q4 2023 → Q4 2024)

MetricQ4 2023Q4 2024
Net Interest Income ($USD Millions)$46.5 $35.1
Other Income ($USD Millions)$4.2 $4.7
Provision for Credit Losses ($USD Millions)$49.5 $4.6
Net Income Attributable to Common ($USD Millions)($18.7) $14.6
Diluted EPS ($USD)($0.27) $0.21
Distributable Earnings (Loss) per share ($USD)($0.37) ($0.21)
Dividend per share ($USD)$0.43 $0.25

Balance Sheet and Capitalization (Q2 → Q3 → Q4 2024)

MetricQ2 2024Q3 2024Q4 2024
Total Assets ($USD Millions)$7,063.8 $6,774.0 $6,350.4
Total Liabilities ($USD Millions)$5,624.5 $5,362.7 $4,951.5
Total Equity ($USD Millions)$1,439.2 $1,411.4 $1,398.9
Common Shareholders’ Equity ($USD Millions)$1,058.4 $1,030.2 $1,017.3
Book Value per Share ($USD)$15.24 $14.84 $14.76
CECL Allowance ($USD Millions)$115 $151 $120
CECL Allowance per Share ($USD)$1.65 $2.17 $1.74

KPIs and Portfolio Metrics

KPIQ2 2024Q3 2024Q4 2024
Loan Repayments Received (Quarter) ($USD Millions)$384.5 $290.0 $457.0
Loan Principal Funded (Quarter) ($USD Millions)$121.5 $55.3 $53.0
Interest Collected (%)96% 100% 100%
Weighted Avg Risk Rating3.1 3.2 3.1
Weighted Avg LTV (%)65% 65% 65%
Outstanding Principal – Senior Loans ($USD Billions)$6.58 $6.34 $5.90
Debt-to-Equity (x)1.9x 1.8x 1.6x
Total Leverage (x)3.9x 3.8x 3.6x
Liquidity ($USD Millions)$644 $638 $685
Share Repurchase (Q4)——859,055 shares; $10.0M at $11.64 avg

Portfolio Composition by Property Type

Property TypeQ2 2024Q3 2024Q4 2024
Multifamily46% 45% 47%
Office20% 20% 19%
Industrial14% 15% 13%
Life Science11% 11% 12%
Hospitality4% 4% 4%
Other5% 5% 5%

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Originations vs RepaymentsNear-term (Q1 2025)Balanced redeployment as portfolio stabilizes (Q3 remarks) “Originations to outpace repayments in the near term” (strong January, no repayments) Raised (more offensive stance)
Repayments OutlookFY 2025“Projecting higher levels in 2025” (Q3) “Repayments expected to exceed $1 billion again this year” (Q4 call) Maintained (explicit >$1B)
Leverage TargetOngoingHigh-3s leverage target (Q2) Total leverage 3.6x; at low end of target; plan to redeploy Maintained
Dividend (Common)Quarterly$0.25 per share (since Q1 2024) $0.25 per share in Q4; declared/paid accordingly Maintained
Preferred DividendQuarterly$0.40625 quarterly ($1.625 annually) $0.40625 declared for March 14, 2025 Maintained
Debt MaturitiesMulti-yearNo final facility maturities until 2026; no corporate debt due until 2027 (Q3) Same reiterated (Q4) Maintained

Earnings Call Themes & Trends

TopicQ2 2024 (Previous Mentions)Q3 2024 (Previous Mentions)Q4 2024 (Current)Trend
Liquidity & FinancingLiquidity $644M; 79% non-MtM; banks retrenching; strong CLOs Liquidity $638M; extended $1B term facility to Sept 2029 Liquidity $685M; 79% non-MtM; robust senior financing availability Improving; extended maturities; steady non-MtM profile
Credit Quality & CECLCECL decreased to $115M via realized losses; watch list stable CECL increased to $151M; watch list at 5 loans CECL decreased to $120M; 92% portfolio rated 3 or better Stabilizing; selective resolutions reducing CECL
Office & Life ScienceTook title to Mountain View office and Seattle life science; patient monetization Watch list includes Minneapolis office; green shoots beginning Green shoots in office/life science; Minneapolis office options; liquidity returning for quality Early improvement for top-tier assets
Multifamily FundamentalsDemand strong; supply cresting in 6–9 months; liquidity ample Multifamily at 45% portfolio; fundamentals resilient Rate sensitivity limited; sponsors de-lever to buy time Resilient; selective supply overhang fades
Origination PipelineShifting to offense; robust pipeline; banks moving to loan-on-loan Positioned to re-enter lending market Originations to outpace repayments; closed ~$225M in Jan; targeting multifamily/industrial/hospitality/data centers, plus Europe Accelerating deployment
Capital AllocationDividend reset to $0.25; leverage targeted high-3s Deleveraging to 3.8x; $0.25 dividend Share repurchase $10M in Q4; balanced buybacks vs originations Opportunistic buybacks; redeployment balance

Management Commentary

  • “This was a year of transition… we have decreased our watch list percentage from 13% as of fourth quarter of 2023 to 8% today… green shoots in the office and life science sectors… patience on these high-quality assets will optimize shareholder value.” — CEO Matt Salem .
  • “We now have 4 watch list loans… we remain confident that we are well beyond the peak stress… we anticipate originations to outpace repayments in the near term.” — President/COO Patrick Mattson .
  • “We continue to feel confident in our offensive positioning… in January, we closed 2 loans for approximately $225 million.” — CEO Matt Salem .
  • “We have strong levels of liquidity with $685 million… 79% of our financing is non-mark-to-market.” — CEO Matt Salem .
  • “As a reminder, as we repatriate the equity in the REO portfolio, we believe we could generate an additional $0.12 per share on our distributable earnings per quarter.” — CEO Matt Salem .

Q&A Highlights

  • Repayments and timing: Management expects >$1B repayments in 2025, likely mid-to-back half; originations already outpaced repayments in January as leverage is at low end of target .
  • Pipeline and asset classes: Focus on institutional sponsors in multifamily, industrial, student housing; select hospitality; potential addition of data centers; geographic diversification into Europe .
  • Office outlook: Early liquidity returning for highest quality assets; well-leased 3-rated office loans should find financing; Minneapolis office remains 5-rated but has resolution flexibility .
  • Multifamily resilience: Limited rate sensitivity in KREF’s multifamily book; sponsors likely to de-lever and extend; liquidity across capital stack remains strong .
  • Capital allocation: Balanced approach between buybacks and new loans; Q4 repurchases totaled $10M at $11.64 average price .
  • Portfolio size potential: Target senior loan portfolio in the ~$6.6–$6.7B range absent REO resolutions at current leverage .

Estimates Context

  • Consensus EPS and revenue estimates from S&P Global were unavailable at the time of analysis due to data access limits; therefore, comparison to Street estimates cannot be provided. If required, we can refresh once access is restored (S&P Global consensus was unavailable via the tool).
  • Management did not issue EPS guidance; commentary indicates DE before realized losses remains a focus metric and additive REO monetization could provide ~$0.12/share tailwind over time .

Key Takeaways for Investors

  • Credit stabilization and lower CECL underpin book value stability, with 92% of the portfolio risk-rated 3 or better and 100% interest collection in Q4 .
  • Offensive posture: originations are set to exceed repayments near term with $224–$225M closed in January and robust pipeline (including data centers and Europe), offering attractive reset-basis lending .
  • Liquidity and financing strength (79% non-MtM; $685M liquidity) provide flexibility to deploy capital and manage maturities (no final facility maturities until 2026; no corporate debt until 2027) .
  • Earnings volatility from realized losses is moderating; Q4 DE loss driven by a single subordinate write-off, while DE before losses was $0.31/share, evidencing underlying cash generation .
  • Portfolio mix remains concentrated in resilient asset classes (60% multifamily/industrial), with improving office/life science sentiment for top-tier assets aiding REO value realization .
  • Buybacks signal valuation discipline; expect balanced capital allocation between repurchases and origination to optimize ROE at reset credit spreads .
  • Near-term trading: stabilization in credit costs and evidence of originations outpacing repayments are potential positive catalysts; medium-term thesis rests on monetizing REO equity and expanding originations at favorable risk-adjusted returns .